BofA raised the firm’s price target on Hutchmed (HCM) to $27 from $26 and keeps a Buy rating on the shares. While noting it sees “some ...
In a report released today, Alec Stranahan from Bank of America Securities reiterated a Buy rating on HUTCHMED (HCM – Research Report), with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback